Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 364793-82-8 | MDL No. : | MFCD00979456 |
Formula : | C11H14BrNO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | DQGAMPWGTUCNGP-UHFFFAOYSA-N |
M.W : | 256.14 | Pubchem ID : | 783082 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.45 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 64.12 |
TPSA : | 12.47 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | Yes |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -10.11 cm/s |
Log Po/w (iLOGP) : | 2.85 |
Log Po/w (XLOGP3) : | -3.17 |
Log Po/w (WLOGP) : | 1.75 |
Log Po/w (MLOGP) : | 2.15 |
Log Po/w (SILICOS-IT) : | 2.96 |
Consensus Log Po/w : | 1.31 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | 0.38 |
Solubility : | 620.0 mg/ml ; 2.42 mol/l |
Class : | Highly soluble |
Log S (Ali) : | 3.48 |
Solubility : | 767000.0 mg/ml ; 3000.0 mol/l |
Class : | Highly soluble |
Log S (SILICOS-IT) : | -3.84 |
Solubility : | 0.0367 mg/ml ; 0.000143 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 0.0 |
Synthetic accessibility : | 1.69 |
Signal Word: | Warning | Class: | |
Precautionary Statements: | P261-P280-P301+P312-P302+P352-P305+P351+P338 | UN#: | |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1704073-29-9 ]
4-(3-bromo-5-methylbenzyl)morpholine
Similarity: 1.00
[ 1119452-92-4 ]
N-(3-Bromobenzyl)-2-methoxy-N-methylethanamine
Similarity: 0.95
[ 1414870-70-4 ]
4-(3-Bromo-4-methylbenzyl)morpholine
Similarity: 0.93
[ 728948-32-1 ]
N-(4-Bromobenzyl)-2-methoxy-N-methylethanamine
Similarity: 0.92
[ 1704073-29-9 ]
4-(3-bromo-5-methylbenzyl)morpholine
Similarity: 1.00
[ 1119452-92-4 ]
N-(3-Bromobenzyl)-2-methoxy-N-methylethanamine
Similarity: 0.95
[ 1414870-70-4 ]
4-(3-Bromo-4-methylbenzyl)morpholine
Similarity: 0.93
[ 728948-32-1 ]
N-(4-Bromobenzyl)-2-methoxy-N-methylethanamine
Similarity: 0.92
[ 1704073-29-9 ]
4-(3-bromo-5-methylbenzyl)morpholine
Similarity: 1.00
[ 1414870-70-4 ]
4-(3-Bromo-4-methylbenzyl)morpholine
Similarity: 0.93
[ 1414870-51-1 ]
4-(2-Bromo-5-methylbenzyl)morpholine
Similarity: 0.88